UCSF (University of California-San Francisco) comes out on embryo cloning work:
This article was originally published in Clinica
The University of California-San Francisco has become the first public institution in the US to confirm that it has been pursuing research on cloning embryos for therapeutic purposes. Embryologist Roger Pedersen led the UCSF project, which began three years ago but has been shelved under the Bush administration. (He left the US to work in Europe in the wake of Senate opposition to therapeutic cloning.) Biotechnology company ACT has also publicly confirmed that it has done research in this area. UCSF's admission is likely to fuel the ongoing US debate.
You may also be interested in...
Tensions between industry and the European Commission on the issue of health claims for botanical food supplements were aired on the second day of the BAH's High Level Conference on the Future of Medicines, with the EC saying the EU Green Deal is now higher up on its list of priorities for the foreseeable future.
Issues over supply and the use of a skinny label have the potential to take a toll on the market for the fish oil drug icosapent ethyl, one analyst has claimed in the wake of Hikma’s recent generic launch.
The German Bundestag has adopted the Unified Patent Court’s draft ratification bill with the necessary qualified majority.